
Chemical and Pharmaceutical Bulletin p. 3211 - 3214 (1991)
Update date:2022-07-29
Topics:
Watanabe
Fukumura
Sasaki
Maeda
Takehara
Aiming at the development of positron-emitting ligands with specific and high affinity toward dopamine D2 receptors in the central nervous system, we synthesized a new fluorinated eticlopride derivative. A fluorine atom was introduced at the C-4 position of the pyrrolidine ring of eticlopride, a dopamine D2 antagonist of the benzamide series. The in vitro binding affinity of this ligand toward the D2 receptor was found to be as potent as eticlopride, suggesting that the corresponding 18F-labelled compound may be useful as an in vivo radioligand for positron emission tomography.
View MoreChangzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
MTT Pharma & Bio-technology Co.,Ltd(expird)
Contact:+86-21-58407925
Address:Room2019, Building C, Tomson Center, No.158, Zhang Yang Road, Shanghai, China
Hefei Lifeon Pharmaceutical Co., Ltd.
Contact:+86-551-65328450
Address:No522 Wangjiang West Road
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
Contact:+86-571-86217390
Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Doi:10.1016/j.molcatb.2013.11.012
(2014)Doi:10.1039/c39920000094
(1992)Doi:10.1080/00304940809458122
(2008)Doi:10.1246/cl.2009.584
(2009)Doi:10.1016/j.bmc.2016.04.041
(2016)Doi:10.1055/s-0029-1217025
(2009)